1. Home
  2. ACET vs VRA Comparison

ACET vs VRA Comparison

Compare ACET & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.47

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

N/A

Current Price

$2.49

Market Cap

72.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
VRA
Founded
1947
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
72.7M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
ACET
VRA
Price
$7.47
$2.49
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$65.33
N/A
AVG Volume (30 Days)
140.1K
150.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
N/A
N/A
Revenue
N/A
$416,097,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.39
52 Week High
$9.05
$3.41

Technical Indicators

Market Signals
Indicator
ACET
VRA
Relative Strength Index (RSI) 52.48 42.97
Support Level $6.54 $2.44
Resistance Level $8.46 $2.52
Average True Range (ATR) 0.46 0.15
MACD -0.01 -0.02
Stochastic Oscillator 49.12 10.87

Price Performance

Historical Comparison
ACET
VRA

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: